Search

Dong Xia Zhang

from Irvine, CA
Age ~60
Get Report
Also known as:
Dong X Zhang, Zhang Dongxia
Related to:
Guifeng Zhang, 67Neng Yong Zhang, 69Jiasheng ZhangJin Y Zhang, 55Shuangjian Zhang, 38Jiasheng S Zhang, 40Lin Zhang, 38Ming J Zhang, 76Mingjun Zhang
Connected to:
Aaron N Zhang, 60Adelaide X Zhang, 48Aiai Zhang, 38Aijun Zhang, 70Airong Zhang, 72Alfred Zhang, 31Anderson Zhang, 34Angeline Zhang, 36Anli Zhang, 68Anming Zhang, 64

Dong Zhang Phones & Addresses

  • Irvine, CA
  • San Gabriel, CA
  • Monterey Park, CA
  • San Francisco, CA
  • Arcadia, CA
  • Oakland, CA
  • San Leandro, CA

Professional Records

Medicine Doctors

Dong Zhang Photo 1

Dr. Dong X Zhang, San Gabriel CA - PHD

View page
Specialties:
Acupuncture
Address:
1025 S San Gabriel Blvd Suite A, San Gabriel, CA 91776
(626) 458-9991 (Fax)
Languages:
English

Resumes

Resumes

Dong Zhang Photo 2

In-House Legal Counsel

View page
Position:
Secretary of the Board & GM of Legal Center at Shanghai NHH Investment Group Co., Ltd.
Location:
Shanghai City, China
Industry:
Commercial Real Estate
Work:
Shanghai NHH Investment Group Co., Ltd. - China since Jun 2011
Secretary of the Board & GM of Legal Center
Dalian Wanda Group - China Mar 2004 - May 2011
Deputy General Manager of Legal Dept.
Education:
Peking University 1994 - 1998
Bachelor, IR/Law
Dong Zhang Photo 3

Principal Partner

View page
Industry:
Oil & Energy
Work:
Dokuz Eylul University
Yã Netici
Zhang & Co Solicitors
Principal Partner
Education:
The Chinese University of Hong Kong 1986 - 1987
Masters, Master of Laws, Law China University of Political Science and Law 1982 - 1986
Bachelors, Bachelor of Law, Political Science
Dong Zhang Photo 4

Senior Analyst

View page
Work:

Senior Analyst
Dong Zhang Photo 5

Dong Zhang

View page
Dong Zhang Photo 6

Dong Zhang

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dong Hao Zhang
Vp And Portfolio Manager
Engemann Asset Management
Unit Investment Trusts, Face-Amount Certifica...
600 N. Rosemead Blvd., Pasadena, CA 91107
Dong Hao Zhang
Vp And Portfolio Manager
Engemann Asset Management
Unit Investment Trusts, Face-Amount Certifica...
600 N. Rosemead Blvd., Pasadena, CA 91107
Dong Pan Zhang
President
Micro Light, Inc
1576 Falling Star Ln, Chino Hills, CA 91709
Dong Zhang
Managing
Africa Stones, LLC
Wholesale Trade of Non-Durable Foods
9108 Huntington Dr, San Gabriel, CA 91775
Dong Liang Zhang
President
PURELAND WINES USA, INC
Whol Wine/Distilled Beverages
260 S Los Robles Ave STE 321, Pasadena, CA 91101
Dong Qing Zhang
President
Dqz Consulting Inc
432 E Garvey Ave, Monterey Park, CA 91755
6886 Vanderbilt St, Chino, CA 91710
Dong Liang Zhang
President
PURELAND IMPORT & EXPORT CORP. USA
560 W Main St STE C #838, Alhambra, CA 91801
Dong Zhang
President
EGM JEWELRY CORP
709 N Hl St STE 21, Los Angeles, CA 90012
Dong Dong Zhang
President
TECHVIEW INT'L, INC
110 E 9 St A448, Los Angeles, CA 90079
110 E 9 St, Los Angeles, CA 90079

Publications

Isbn (Books And Publications)

Case-Based Reasoning in Design

View page
Author

Dong Mei Zhang

ISBN #

0805818316

Case-Based Reasoning in Design

View page
Author

Dong Mei Zhang

ISBN #

0805818324

Japan and China: Rivalry or Cooperation in East Asia?

View page
Author

Dong Dong Zhang

ISBN #

0731536320

Wikipedia References

Dong Zhang Photo 7

Dong Zhang

Work:
Position:

Chief of Staff • Chancellor • Governor

Business category:

Salt • Governors

Education:
Area of science:

Military law

Skills & Activities:
Military rank:

Major General • Commander

Master status:

Empress • Subordinate

Skill:

Reconciliation • Initiative • Instruction • Empress

Preference:

Ally

Us Patents

Methods Of Stimulating Erbb4 Receptor Phosphorylation

View page
US Patent:
7846453, Dec 7, 2010
Filed:
Jun 15, 2006
Appl. No.:
11/454635
Inventors:
Paul J. Godowski - Burlingame CA, US
Melanie Rose Mark - Burlingame CA, US
Dong Xiao Zhang - Burlingame CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/00
A61K 38/18
C07K 14/475
US Classification:
4241981, 4241851, 514 12, 530350, 530399
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Erbb4 Receptor-Specific Neuregulin Related Ligands And Uses Therefor

View page
US Patent:
20020161200, Oct 31, 2002
Filed:
Apr 29, 2002
Appl. No.:
10/136573
Inventors:
Paul Godowski - Burlingame CA, US
Melanie Mark - Burlingame CA, US
Dong Zhang - Burlingame CA, US
Assignee:
Genentech, Inc.
International Classification:
C07K016/28
C07K014/485
US Classification:
530/388240, 530/350000
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Erbb4 Receptor-Specific Neuregulin Related Ligands And Uses Therefor

View page
US Patent:
20030036166, Feb 20, 2003
Filed:
Aug 9, 2002
Appl. No.:
10/215862
Inventors:
Paul Godowski - Burlingame CA, US
Melanie Mark - Burlingame CA, US
Dong Zhang - Burlingame CA, US
Assignee:
Genentech, Inc.
International Classification:
C07K014/475
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/069100, 435/320100, 435/325000, 530/399000, 536/023500
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Erbb4 Receptor-Specific Neuregulin Related Ligands And Uses Therefor

View page
US Patent:
20050136467, Jun 23, 2005
Filed:
Jan 14, 2005
Appl. No.:
11/035787
Inventors:
Paul Godowski - Burlingame CA, US
Melanie Mark - Burlingame CA, US
Dong Zhang - Burlingame CA, US
International Classification:
C12Q001/68
G01N033/53
G01N033/567
C07H021/04
US Classification:
435006000, 435007200, 435069100, 435320100, 435325000, 530399000, 530388240, 536023500
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Erbb4 Receptor-Specific Neuregulin Related Ligand Antibodies And Uses Therefor

View page
US Patent:
62520512, Jun 26, 2001
Filed:
Jul 30, 1998
Appl. No.:
9/126121
Inventors:
Paul J. Godowski - Burlingame CA
Melanie Rose Mark - Burlingame CA
Dong Xiao Zhang - Burlingame CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 1600
C12P 2108
C12N 506
C12N 516
US Classification:
5303881
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Erbb4 Receptor-Specific Neuregolin Related Ligands And Uses Therefor

View page
US Patent:
61214159, Sep 19, 2000
Filed:
Jul 24, 1997
Appl. No.:
8/899437
Inventors:
Paul J. Godowski - Burlingame CA
Melanie Rose Mark - Burlingame CA
Dong Xiao Zhang - Burlingame CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3800
A61K 3824
C07K 100
US Classification:
530324
Abstract:
The invention concerns a novel neuregulin related ligand (NRG3) including fragments and variants thereof, as new members of the neuregulin family of compounds. The invention also concerns methods and means for producing NRG3. The native polypeptides of the invention are characterized by containing an extracellular domain including an EGF-like domain, a transmembrane domain and a cytoplasmic domain. Isolated nucleotide sequences encoding such polypeptides, expression vectors containing the nucleotide sequences, recombinant host cells transformed with the vectors, and methods for the recombinant production for the novel NRG3s are also within the scope of the invention.

Combination Therapy With Glutaminase Inhibitors

View page
US Patent:
20170333430, Nov 23, 2017
Filed:
May 3, 2017
Appl. No.:
15/585523
Inventors:
- South San Francisco CA, US
Andrew L. MacKinnon - San Francisco CA, US
Mirna L. Rodriguez - San Jose CA, US
Dong Zhang - San Jose CA, US
Francesco Parlati - San Francisco CA, US
International Classification:
A61K 31/501
A61K 31/517
A61K 31/436
A61K 31/502
A61N 5/10
A61K 45/06
Abstract:
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an anticancer agent such as an enzyme inhibitor (such as a kinase inhibitor), a mitotic inhibitor, a DNA-modifying agent, or a cytidine analog. The invention further relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases that are resistant to one or more anticancer agents.

Treatment Of Lung Cancer With Inhibitors Of Glutaminase

View page
US Patent:
20160287585, Oct 6, 2016
Filed:
Apr 6, 2016
Appl. No.:
15/091816
Inventors:
- South San Francisco CA, US
Melissa G. Works - Menlo Park CA, US
Mirna L. M. Rodriguez - San Jose CA, US
Dong Zhang - San Jose CA, US
International Classification:
A61K 31/501
C12Q 1/68
A61K 31/4184
Abstract:
The invention relates to methods of treating lung cancer using glutaminase inhibitors. In particular, results demonstrate that lung cancers characterized by an EGFR or KRAS mutation are treated by glutaminase inhibitors.
Control profile
Dong Xia Zhang from Irvine, CA, age ~60 Get Report